ÂÜÀòÂÒÂ×

Megan Sniecinski has served as the Chief Business Officer since December 2021. Prior to joining us, Ms. Sniecinski was at BioCryst Pharmaceuticals, where she served as Chief Business Officer from July 2019 to August 2021. Previously, Ms. Sniecinski held senior leadership roles at PTC Therapeutics, Inc. from September 2014 to June 2019, culminating as senior vice president of business operations and program management. Prior to joining PTC Therapeutics, Inc., Ms. Sniecinski worked at Merck for more than 12 years, serving in a diverse set of operational and strategic roles with increasing responsibility. Ms. Sniecinski received a B.S. in chemical engineering from the University of Virginia and an MBA from the Wharton School of the University of Pennsylvania.